Stratégies réglementaires pour le développement et l'approbation précoce des dispositifs médicaux.
PMID : 35485732 ·
D, a, v, i, d, , R, , H, o, l, m, e, s, ;, , R, i, c, k, , G, e, o, f, f, r, i, o, n, ;, , J, o, n, , H, u, n, t, ;, , R, o, b, e, r, t, , C, h, i, p, , H, a, n, c, e, ;, , M, a, r, t, i, n, , B, , L, e, o, n, ;, , M, i, c, h, a, e, l, , J, , M, a, c, k, ;, , A, a, r, o, n, , V, , K, a, p, l, a, n
Publicité
Résumé
The development of new technology to treat unmet clinical needs is an important component of modern cardiovascular disease. The need for this has been emphasized in the past several years beginning with the Food and Drug Administration (FDA) guidance document on Early Feasibility Studies in 2012 and then the 21st Century Cures legislation. A number of steps need to be considered in this process by the stakeholders involved including physician innovators and scientists, professional societies suc
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.